Release Notes Medtech32 - Medtech Global · for primary vaccination in children at 15 months, and for previously unvaccinated children turning 11 years on or after 1 July 2017 who

© Copyright Medtech Limited Page 1 of 28

EMPOWERING HEALTH

Release Notes

Medtech32

Version 22.9 – Build 5424

(June 2017)

These release notes contain important information for Medtech32 users. Please ensure that

they are circulated among all relevant staff. We suggest that they are filed safely for future

reference.


EMPOWERING HEALTH

Table of Contents

Introduction 4

NEW ENHANCEMENTS 4

Changes to the National Immunisation Schedule July 2017 5

New 2017 Immunisation Schedules 6

SETUP OF 2017 IMMUNISATION SCHEDULES 6

IMMUNISATION SCHEDULES FOR 2017 7

TRANSITIONING PATIENTS FROM THE 2014 IMMUNISATION SCHEDULE 8

Rotavirus Monovalent Vaccination 11

NEW ROTAVIRUS MONOVALENT VACCINE 11

Pneumococcal Vaccination 12

CHANGES TO PNEUMOCOCCAL VACCINATION 12

Varicella Vaccination 13

NEW VARICELLA VACCINES 13

HPV9 Vaccination 15

INCLUDING HPV9 VACCINES WITHIN CHILDHOOD IMMUNISATION SCHEDULE 15

New High Risk Vaccinations 18

SETUP OF HIGH RISK VACCINES 18

NEW HIGH RISK VACCINES 18

Increase in Dosage Interval between 23PPV Vaccines 23

CHANGES TO 23PPV VACCINE-CONTAINING SCHEDULES 23

Changes to Valid Alternatives of Tdap-11y Vaccine 25

ADDITION OF NEW VALID ALTERNATIVE VACCINE FOR TDAP-11Y 25

MESSAGING OF ALL VALID ALTERNATIVES OF TDAP-11Y VACCINE TO NIR 26

General Changes 27

MEDTECH32 IMMUNISATION AUDIT REPORT 27

NIR IMMUNISATION AUDIT REPORT 27


EMPOWERING HEALTH

IMMUNISATION MERGE FIELD 27

OUTBOX DOCUMENT WIZARD 27

PROVIDER INBOX – VACCINE UPDATE MESSAGES 27

LINK TO 2017 IMMUNISATION HANDBOOK FROM IMMUNISATION SCREEN 27


EMPOWERING HEALTH

Introduction

These release notes provide an overview of the enhancements made within Medtech32

Version 22.9 Build 5424 to support the new NIR schedule changes that will come into effect

from 1 July 2017.

New Enhancements

Description of Change Category Impact

The following changes have been made in Medtech32 to support the

Ministry of Health’s requirements for the July 2017 NIR Schedule

changes:

Creation of a new Childhood Immunisation Schedule for 2017

Creation of new Catch-Up Schedules for 2017

Creation of a new Baby of Hepatitis B Mother Schedule for 2017

Pneumococcal 10-valent protein conjugate vaccine (PCV10) has

replaced the pneumococcal 13-valent protein conjugate vaccine

(PCV13) in the Childhood Immunisation Schedule for 2017

Rotavirus monovalent vaccine has replaced the rotavirus

pentavalent vaccine. This new vaccine must be given at 6 weeks

and 3 months only; a third vaccination at 5 months is no longer

required

Varicella vaccine has been added to the Childhood Immunisation

Schedule for 2017, with a single dose to be given at 15 months

A standalone Varicella vaccine has been included to be given at

11 years of age, if the patient has never had a Varicella infection or

has not previously received the Varicella vaccine

HPV9 vaccines have been introduced under the Childhood

Immunisation Schedule for 2017

New High Risk vaccines have been created for the following:

PCV13, Hib, Meningococcal B, Hepatitis B (Paed/Adol), Hepatitis B

(Adult)

The interval between the two 23 PPV vaccine doses has been

increased from 3 years to 5 years

Ensure that all alternative vaccines to Tdap-11 years are being sent

to NIR

Regulatory Major


EMPOWERING HEALTH

Changes to the National Immunisation

Schedule July 2017

The Ministry of Health has confirmed the following changes to the National Immunisation

Schedule, effective from 1 July 2017.

The 13-valent pneumococcal vaccine [Prevenar 13; PCV13] will be replaced by the

10-valent PCV10 vaccine [Synflorix].

Prevenar 13 (PCV13) will remain available for high-risk patients only.

Under the Childhood Immunisation Schedule, the three-dose rotavirus pentavalent

vaccine [RotaTeq] schedule will be replaced by a two-dose rotavirus monovalent

vaccine [Rotarix] schedule, except where a patient has started the rotavirus

pentavalent vaccine schedule. In this scenario, the patient will be able to complete

their original three-dose regimen with Rotarix (monovalent) or, while stocks remain, with

RotaTeq (pentavalent).

Funded access to the Varicella vaccine (Varilrix) will be widened to include one dose

for primary vaccination in children at 15 months, and for previously unvaccinated

children turning 11 years on or after 1 July 2017 who have not had a previous Varicella

(chickenpox) infection.

From 1 July 2017, the Human Papillomavirus 9 valent Vaccine (HPV9) will be scheduled

within the Childhood Immunisation Schedule in MedTech32 and not as a standalone

HPV schedule.

New High Risk vaccines will be messaged to NIR. The new high-risk vaccines are Hib,

PCV13, Meningococcal B, Hepatitis B (Adol/Paed) and Hepatitis B (Adult).

Increase in the dosage interval period between 23PPV Dose 1 and 23PPV Dose 2 from

three years to five years.

Ensuring that there are no messaging restrictions (like Birth Cohort rules) for any valid

alternative to the Tdap-11y vaccine.


EMPOWERING HEALTH

New 2017 Immunisation Schedules

Setup of 2017 Immunisation Schedules

Setup ► Recall/Screening ► Immunisation Schedule

The following new schedules have been added to Medtech32 for the 2017 Immunisation

Schedule changes:

New Schedules Schedule Details

Childhood Immunisation Schedule Childhood Immunisation Schedule 2017

Hepatitis B Schedule Baby of HepB Positive Mother 2017

Catch-Up Schedules

Std CU 12-14 wks 1st dose 2017

Std CU 15 wks-6 mths 1st dose 2017

Std CU 7-11 mths 1st dose 2017




Std CU 5-9yrs 1st dose 2017

Std CU 10-17 yrs 1st Dose 2017

Std CU 18+ yrs 1st Dose 2017

Std CU 11-14 yrs 1st dose (HPV9 only)

2017

Std CU 15-26 yrs 1st dose (HPV9 only)

2017

Please note: the Catch-Up schedules will not have dose of the HPV9 vaccine available as part

of the schedule 11 year vaccination tasks. Instead there are two separate HPV9 Catch-Up

schedules for the age groups of 1114 years and 1526 years; these can be used based on

the patient’s age at the time of vaccination.

Under the Catch-Up Schedule Setup screen, the HPV9 Vaccine Groups have been added by

default in the Group Members tab. This is due to the presence of a corresponding 11Y17 Group.

But as stated above, the 11-year-old HPV9 vaccine tasks will not be available in the Catch-Up

Schedules.


EMPOWERING HEALTH

Immunisation Schedules for 2017

Module ► Immunisations

The new 2017 Immunisation Schedules replace the current 2014 Immunisation Schedules and

will be available for selection under the Schedule Selection tab of the Immunisation module.

All the new schedules include tasks for the new rotavirus monovalent vaccine (at ages 6W &

3M), Varicella vaccine (at age 15M) and HPV9 vaccine (at age 11Y).

The PCV13 vaccine has been replaced with PCV10 (at ages 6W, 3M, 5M & 15M).


EMPOWERING HEALTH

Transitioning patients from the 2014 Immunisation Schedule

Children aged less than 6 weeks (5 weeks and 6 days) on 1 July 2017 will be added to the new

Childhood Immunisation Schedule for 2017.

Children who are due or overdue for their 6W, 3M, 5M or 15M immunisations (under the

Childhood Immunisation Schedule 2014) on or after 1 July 2017 will be transferred to the new

Childhood Immunisation Schedule for 2017. This will enable them to receive the new rotavirus

monovalent, PCV10 and Varicella vaccines.

After moving to the new 2017 Childhood Immunisation schedule, the following changes will be

noted:

If the child has received PCV13 vaccination under the 2014 schedule, then on

transferring to the new 2017 schedule, vaccination with the PCV10 vaccine under the

new schedule will be updated with the ‘Alternative Given’ outcome.

If the child has received the DTaP-IPV-HepB/Hib vaccine under the 2014 schedule, then

on transferring to the new 2017 schedule, the DTaP-IPV-HepB/Hib vaccine in the new

schedule will be updated with the ‘Given’ outcome.

All vaccines received under the 2014 schedule will be displayed under the All

Immunisation tab.

There are special transition rules for the rotavirus vaccines and these are outlined below:

Number of Rotavirus Pentavalent

doses received under 2014 Schedule

Number of Rotavirus Monovalent doses required

in New Schedule

3 Rotavirus pentavalent doses No Rotavirus monovalent doses required

2 Rotavirus pentavalent doses

(i.e. received doses at 6W & 3M, did

not receive third dose at 5M)

a. According to the Ministry of Health, one dose of

the Rotavirus monovalent vaccine must be

given to the patient; the interval between this

dose and the second Rotavirus pentavalent

dose (given under the 2014 schedule) must be

more than 4 weeks.

The Rotavirus mono, Dose 2 vaccine will be

given to the patient under the 5 months

schedule.

b. The Rotavirus mono, Dose 1 under the CI 2017

schedule will be automatically updated with the

status of ‘Alternative Given’ and will be

displayed under the 6 weeks schedule.

c. If the patient’s age is older than 24 weeks and

6 days, and the Rotavirus mono, Dose 2 has not

been given, then this vaccine will be

automatically closed-off with the status of

‘Closed Not Required’ (Rotavirus mono, Dose 1

will have the status of ‘Alternative Given’)


EMPOWERING HEALTH

Number of Rotavirus Pentavalent

doses received under 2014 Schedule

Number of Rotavirus Monovalent doses required

in New Schedule

1 Rotavirus pentavalent dose

(i.e. received 1 dose at 6W, did not

receive the second and third doses

at 3M & 5M)

a. According to the Ministry of Health, two doses of

the Rotavirus monovalent vaccine doses must

be given to the patient. A minimum gap of at

least 4 weeks must be maintained between the

two doses.

b. The patient will receive Rotavirus mono, Dose 1

under the 3 months schedule.

c. Rotavirus mono, Dose 2 will be administered

under the 5 months schedule.

d. If the patient’s age is greater than 24 weeks and

6 days, and the Rotavirus mono, Dose 1 and

Rotavirus mono, Dose 2 have not been given,

then these vaccines will be automatically

closed-off with the status of ‘Closed Not

Required’

The screenshot given below displays the transition of a patient from 2014 to 2017 Childhood

Immunisation Schedule who have immunisations due under the 3M, 5M and 15M groups.

Similarly the screenshot given below displays the transition of a patient from 2014 to 2017

Childhood Immunisation Schedule who have immunisations due under the 5M and 15M

groups.


EMPOWERING HEALTH

Please note: there will be a Transition Utility available in the Medtech32 Version 22.9 Build 5424.

After installing this build, the transition utility will be triggered when the first user at the practice

logs into Medtech32 on or after 1 July 2017.


EMPOWERING HEALTH

Rotavirus Monovalent Vaccination

New Rotavirus Monovalent Vaccine

Setup ► Recall/Screening ► Vaccine


A new Rotavirus vaccine has been added under the 2017 Immunisation Schedules. This

vaccine will be available under the scheduled 6-week and 3-month vaccination tasks.

Vaccine Codes Vaccine Names

ROTAM1 Rotavirus mono, Dose1

ROTAM2 Rotavirus mono, Dose2

The child will not be able to receive their first dose of the rotavirus monovalent vaccine if they

are older than 14 weeks and 6 days.

If the child is older than 14 weeks and 6 days and they have not received their first dose of the

vaccine, then the incomplete Rotavirus vaccination tasks (both 1st and 2nd doses) will be

updated automatically with the Outcome status of ‘Closed Not Required’.

Similarly, both the Rotavirus Monovalent vaccination tasks must be completed by the age of

24 weeks and 6 days.

If the child is older than 24 weeks and 6 days and they have not completed the Rotavirus

vaccination tasks (second dose not yet given), then the incomplete Rotavirus vaccination task

will be automatically updated with the Outcome status of ‘Closed Not Required’.


EMPOWERING HEALTH

Pneumococcal Vaccination

Changes to Pneumococcal Vaccination



Under the 2014 schedules, the PCV13 vaccine was available for administration to children at

age 6W, 3M, 5M and 15M. This vaccine has been replaced with the PCV10 vaccine in all

immunisation schedules for 2017.


PC10-1 Pneum, conj 10, 6w

PC10-2 Pneum, conj 10, 3m



The change from PCV13 to PCV10 vaccination is only for the 2017 Childhood Immunisation

Schedule, Catch-Up schedules and Baby of Hep B Mother schedules.

Please note: the PCV13 vaccine will not be replaced with PCV10 vaccine under the 2014

Pneumococcal Schedules.

The PCV13 vaccine will still be available as a valid alternative to the new PCV10 vaccine.


EMPOWERING HEALTH

Varicella Vaccination

New Varicella Vaccines



A new Varicella vaccine has been added under the 2017 Childhood Immunisation Schedule.

From 1 July 2017 all individuals born on or after 1 April 2016 are eligible to receive the Varicella

vaccine, which will be available under the 15-month vaccination tasks.


VAR15M Varicella 15m

VAR11Y Varicella 11y

Children who are due or overdue for their 15-month vaccination tasks under the 2014 schedule

will be transitioned into the 2017 Childhood Immunisation Schedule so that they will receive

the Varicella 15-month vaccination task.

The Varicella vaccine (Varicella 11y) can be administered to 11 years old outside of the

Childhood Immunisation Schedule, via the Single Syringe icon under the Immunisation

Schedule tab and the All Immunisations tab. However, this is restricted to previously

unvaccinated children turning 11 years old on or after 1 July 2017 who have not had a previous

Varicella infection (chickenpox).


EMPOWERING HEALTH


EMPOWERING HEALTH

HPV9 Vaccination

Including HPV9 Vaccines within Childhood Immunisation Schedule


From 1 July 2017, the HPV9 vaccination tasks (for children aged 1114 years) will be scheduled

within the Childhood Immunisation programme in Medtech32 and not as a standalone HPV9

Vaccine programme.

By default, the schedule will have three doses of the HPV9 vaccine with the first vaccine

scheduled when the child is aged 11 years. The schedule dosage intervals are as follows:

HPV9 – Dose 1 (at age 11 years)

HPV9 – Dose 2 (6 months after Dose 1)

HPV9 – Dose 3 (4 months after Dose 2)

As per the Ministry of Health guidelines, based on a child’s age and the intervals between the

doses, the total number of HPV9 doses to be given will vary.

The details for these dosage variations are given below:

1. If the child receives the first two doses of the HPV9 vaccine, at least 5 months apart,

then they do not have to receive a third dose of the HPV9 vaccine. In this scenario, the

HPV9 Dose 3 can be manually closed off with the Outcome of Closed Not Required.

2. If the child receives the first two doses of the HPV9 vaccine, less than 5 months apart,

then they must receive a third dose of the HPV9 vaccine to be fully immunised.

3. If the child does not receive their second HPV9 dose by age 14 years and 364 days,

then they must receive the remaining two doses of the HPV9 vaccine to be fully

immunised.


EMPOWERING HEALTH

The existing standalone vaccination schedule of ‘HPV9 Vaccine Schedule 9-14 yrs’ will be

available to cater to the 914 year age group. This schedule can be used under the following

circumstance:

Children who are on an older immunisation schedule (e.g. 2014, 2011, 2008, etc.) that

does not include the HPV9 vaccine doses.

Similarly the existing standalone vaccination schedule of ‘HPV9 Vaccine Schedule 15-26 yrs’

will be available to cater to the 1526 year age group. This schedule can be used under the

following circumstances:

Children who are on an older immunisation schedule (e.g. 2014, 2011, 2008, etc.) that

does not include the HPV9 vaccine doses.

If the child has not started the HPV9 Dose 1 vaccine, available under the 2017

Immunisation Schedule by age 15 years, then the practice must use this standalone

schedule to complete the required HPV9 doses.


EMPOWERING HEALTH


EMPOWERING HEALTH

New High Risk Vaccinations

Setup of High Risk Vaccines


Various new High Risk funded vaccines have been introduced in Medtech32.

Vaccine Codes Vaccine Names Purpose

PCV13H PCV13 High Risk

To be given to high-risk children (not covered

by current pneumococcal programme) and

high-risk adults

HIBHR Hib High Risk To be given to high-risk children and adults

MENBHR MenB High Risk

To be given to high-risk children and adults

during an outbreak of Meningococcal B

infection in NZ

HEPBHR HepB Paed High Risk To be given to high-risk children and

adolescents

HEPBAH HepB Adult High Risk To be given to high-risk adults

New High Risk Vaccines


The new High Risk vaccines will cater to high-risk children and adults.

These High Risk vaccines will be available for selection via the Single Syringe icon under the

Immunisation Schedule tab and the All Immunisations tab.

These vaccines will be messaged to NIR irrespective of the patient’s age.


EMPOWERING HEALTH


EMPOWERING HEALTH


EMPOWERING HEALTH


EMPOWERING HEALTH


EMPOWERING HEALTH

Increase in Dosage Interval between 23PPV

Vaccines

Changes to 23PPV Vaccine-containing Schedules

Setup ► Recall/Screening ► Vaccine Group


Based on a directive from the Ministry of Health, the dosage interval between the two 23 PPV

vaccine doses (Pneum, poly 1st & Pneum, poly 2nd) has been increased from 3 years to 5 years.

This has been implemented by updating the ‘Due at Age’ date or ‘Due from Schedule Start’

date for all vaccine groups containing the second 23PPV dose.

If a patient is already on an immunisation schedule containing the 23PPV vaccine, then the

recall period will be amended from 3 years to 5 years for the second dose of 23PPV (Pneum,

poly 2nd vaccine).


EMPOWERING HEALTH

This change in the dosage intervals between two 23PPV vaccines will affect the following

immunisation schedules:

1. Pneum schedule (6W to 6M) 2014

2. Pneum schedule (7M to 11M) 2014



5. Pneum 1 prev PCV (2 to 5Y) 2014




9. Pneum 1 prev 23PPV (2 to 5Y) 2014

10. Pneum schedule (6W to 6M) 2011








18. Pneum 1 prev 23PPV (2 to 5Y) 2011

19. Pneum schedule (6W to 6M)

20. Pneum schedule (7M to 11M)



23. Pneum 1 prev PCV (2 to 5Y)




27. Pneum 1 prev 23PPv (2 to 5Y)


EMPOWERING HEALTH

Changes to Valid Alternatives of Tdap-11y

Vaccine

Addition of new Valid Alternative Vaccine for Tdap-11y


The Tdap-11y vaccine given to children at age 11 years was missing the IPV vaccine as an

Alternative Given selection option. The IPV vaccine has now been added.

With the addition of this alternative vaccine, the different Alternative Given selection options

available for Tdap-11y vaccine are as follows:

1. TT11y

2. Td11y

3. d11y

4. dTap-IPV 11y

5. IPV misc/11y


EMPOWERING HEALTH

Messaging of all Valid Alternatives of Tdap-11y Vaccine to NIR

All valid alternative vaccines given for Tdap-11y vaccine will be sent to NIR, irrespective of the

patient’s Date of Birth (the Age Cohort rule will be disabled for this).

Currently, the Age Cohort rule states that immunisation details will be sent to NIR only for those

patients whose Date of Birth (DoB) falls after the NIR Go Live date.

As part of the change, for a patient who receives one of the valid alternative vaccines for

Tdap-11y vaccine, the vaccine details will be sent to NIR even if the patient’s DoB falls before

the NIR Go Live date.


EMPOWERING HEALTH

General Changes

Medtech32 Immunisation Audit Report

Report ► Immunisations ► MT32 Imm Audit

The Medtech32 Immunisation Audit Report has been updated to include the new 2017

Childhood Immunisation Schedule vaccines.

NIR Immunisation Audit Report

Report ► Immunisations ► NIR Imm Audit

The NIR Immunisation Audit Report has been updated to include the new 2017 Childhood

Immunisation Schedule vaccines.

Immunisation Merge Field

Setup ► In/OutBox ► Outbox Document

The Immunisation merge field has been updated to include the new 2017 Immunisation

Schedule vaccines.

Outbox Document Wizard

Module ► Out Box ► New Document (Wizard Button)

The Immunisations section in the More tab of the Out Box Document Wizard has been updated

to include the new vaccine codes for the 2017 Immunisation Schedules.

Provider Inbox – Vaccine Update Messages

Module ► Inbox ► Provider Inbox

The Provider Inbox display for Immunisation Update messages has been updated to ensure

correct formatting and display of 2017 Immunisation Schedule vaccines, when importing these

vaccines for different patients.

Link to 2017 Immunisation Handbook from Immunisation Screen


A new Help icon has been added under the Immunisation Status screen. Clicking this icon

will open the PDF version of the latest 2017 Immunisation Handbook.


EMPOWERING HEALTH

For further information or any other queries, please contact Medtech Support via:

Medtech32 application [Help ► Contact Support]

Online chat: www.medtechglobal.com

Email: [email protected]

Phone: 0800 2 MEDTECH (633 832)

http://www.medtechglobal.com/

mailto:[email protected]

Release Notes Medtech32 - Medtech Global · for primary vaccination in children at 15 months, and for previously unvaccinated children turning 11 years on or after 1 July 2017 who

Documents